CLINICAL_TRIALS
trial_result
· 2021-03-11
Clinical Trial Update: 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating 18F-Fluorothymidine to assess treatment response in lymphoma has terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-03-11